Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: A nationwide proficiency study

被引:0
|
作者
Fernandez-Cuenca, Felipe [1 ,2 ,3 ]
Lopez-Hernandez, Inmaculada [1 ,2 ,3 ]
Cercenado, Emilia [4 ,5 ,6 ]
Conejo, Maria Carmen [7 ]
Tormo, Nuria [8 ,9 ]
Gimeno, Concepcion [8 ,9 ]
Pascual, Alvaro [1 ,2 ,3 ,7 ]
机构
[1] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol C, Seville, Spain
[2] Univ Seville, Hosp Univ Virgen Macarena, Inst Biomed Sevilla IBIs, CSIC, Seville, Spain
[3] Inst Salud Carlos III, Spanish Network Res Infect Dis REIPI RD16 0016, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Serv Microbiol & Enfermedades Infecciosas, Madrid, Spain
[5] Univ Complutense, Fac Med, Dept Med, Madrid, Spain
[6] Ctr Invest Biomed Red Enfermedades Resp, CIBERES, CB06 06 0058, Madrid, Spain
[7] Univ Seville, Dept Microbiol, Seville, Spain
[8] Hosp Gen Valencia, Serv Microbiol, Valencia, Spain
[9] Spanish Soc Clin Microbiol & Infect Dis SEIMC, Qual Control Programme CCS, Valencia, Spain
来源
关键词
Enterococcus spp; Quality control; Vancomycin resistance; Antimicrobial susceptibility; National multicenter study; TEICOPLANIN RESISTANCE; VITEK; 2; EPIDEMIOLOGY; INFECTIONS;
D O I
10.1016/j.eimc.2021.11.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The ability of Spanish microbiology laboratories to (a) determine antimicrobial suscepti-bility (AS), and (b) correctly detect the vancomycin resistance (VR) phenotype in vancomycin-resistant Enterococcus spp. (VRE) was evaluated.Methods: Three VRE isolates representing the VanA (E. faecium), VanB (E. faecium) and VanC (E. gallinarum) VR phenotypes were sent to 52 laboratories, which were asked for: (a) AS method used; (b) MICs of ampicillin, imipenem, vancomycin, teicoplanin, linezolid, daptomycin, ciprofloxacin, levofloxacin and quinupristin-dalfopristin, and high-level resistance to gentamicin and streptomycin; (c) VR phenotype.Results: (a) The most frequently used system was MicroScan; (b) according to the system, the highest percentage of discrepant MICs was found with gradient strips (21.3%). By antimicrobial, the high-est rates of discrepant MICs ranged 16.7% (imipenem) to 0.7% (linezolid). No discrepant MICs were obtained with daptomycin or levofloxacin. Mayor errors (MEs) occurred with linezolid (1.1%/EUCAST) and ciprofloxacin (5.0%/CLSI), and very major errors (VMEs) with vancomycin (27.1%/EUCAST and 33.3%/CLSI) and teicoplanin (5.7%/EUCAST and 2.3%/CLSI). For linezolid, ciprofloxacin, and vancomycin, discrepant MICs were responsible for these errors, while for teicoplanin, errors were due to a misassignment of the clinical category. An unacceptable high percentage of VMEs was obtained using gradient strips (14.8%), especially with vancomycin, teicoplanin and daptomycin; (c) 86.4% of the centers identified VanA and VanB phenotypes correctly, and 95.0% the VanC phenotype.Conclusion: Most Spanish microbiology laboratories can reliably determine AS in VRE, but there is a significant percentage of inadequate interpretations (warning of false susceptibility) for teicoplanin in isolates with the VanB phenotype.& COPY; 2021 Sociedad Espanola de Enfermedades Infecciosas y Microbiologi & PRIME;a Cli & PRIME;nica. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [1] Reporting antimicrobial susceptibilities and resistance phenotypes in Staphylococcus spp.: a nationwide proficiency study
    Fernandez-Cuenca, Felipe
    Lopez-Hernandez, Inmaculada
    Cercenado, Emilia
    Conejo, Carmen
    Tormo, Nuria
    Gimeno, Concha
    Pascual, Alvaro
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (05) : 1187 - 1196
  • [2] Proficiency of clinical laboratories in spain in detecting vancomycin-resistant Enterococcus spp.
    Alonso-Echanove, J
    Robles, B
    Jarvis, WR
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) : 2148 - 2152
  • [3] Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: a nationwide proficiency study
    Fernandez-Cuenca, Felipe
    Tomas, Maria
    Caballero-Moyano, Francisco-Javier
    Bou, German
    Pascual, Alvaro
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (03) : 692 - 697
  • [4] Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan
    Hsueh, PR
    Wu, JJ
    Lu, JJ
    Teng, LJ
    Luh, KT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (01) : 45 - 48
  • [5] Surveillance of multiresistance: Vancomycin-resistant Enterococcus spp.
    Jose Gonzalez-Abad, Maria
    Alonso Sanz, Mercedes
    ANALES DE PEDIATRIA, 2019, 91 (04): : 267 - 268
  • [6] Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia
    Libisch, Balazs
    Lepsanovic, Zorica
    Top, Janetta
    Muzslay, Monika
    Konkoly-Thege, Marianne
    Gacs, Maria
    Balogh, Boglarka
    Fuzi, Miklos
    Willems, Rob J.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (10) : 778 - 784
  • [7] In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci
    Evans, PA
    Norden, CW
    Rhoads, S
    Deobaldia, J
    Silber, JL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1406 - 1406
  • [8] Evaluation of the antimicrobial activity of daptomycin and linezolid against vancomycin-resistant Enterococcus spp. isolates in south India
    Laishram, Shakti
    Sahni, Rani D.
    Anandan, Shalini
    Balaji, Veeraragavan
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (03) : 194 - 197
  • [9] Two Screening Assays to Detect Vancomycin-Resistant Enterococcus spp.
    Cenci-Goga, Beniamino T.
    Karama, Musafiri
    El-Ashram, Saeed
    Saraiva, Cristina
    Garcia-Diez, Juan
    Chalias, Athanasios
    Grispoldi, Luca
    MICROBIOLOGY RESEARCH, 2022, 13 (02) : 332 - 341
  • [10] Comparative in vitro antimicrobial activity of tigecycline against clinical isolates of vancomycin-resistant enterococcus
    Yemisen, M.
    Demirel, A.
    Mete, B.
    Kaygusuz, A.
    Mert, A.
    Tabak, F.
    Ozturk, R.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 27 (04) : 373 - 374